Summarized by Daily Strand AI from peer-reviewed source
10x Genomics has introduced a new platform called Atera, designed to advance a field known as spatial biology. This technology allows scientists to examine the "whole transcriptome", which is the complete set of active genetic instructions inside a cell, while keeping those cells in their original physical location within a tissue sample. In the past, researchers had to choose between how much tissue they could scan, how much genetic detail they could capture, and how quickly they could process it. Atera aims to eliminate these compromises entirely.
Compared to the company's previous Xenium platform, Atera represents a major leap in performance. It can process samples four times faster, analyze 3.6 times more genetic targets, and is up to three times more sensitive when reading a cell's complete genetic activity. To make the system easier for doctors and researchers to adopt, it uses standard glass microscope slides, which fits smoothly into traditional laboratory and pathology workflows.
Early testing has already shown the platform's potential in cancer research. By examining a single sample from a colorectal tumor, scientists were able to successfully map out cancer cells, stem cells, and the surrounding immune system. This allowed them to see exactly how these different groups of cells interact in their natural microscopic neighborhood.
Being able to see both the exact location and the complete genetic activity of cells is a massive step forward for understanding complex diseases. By mapping the intricate neighborhood of a tumor, scientists can better understand how malignant cells survive and interact with the immune system. This detailed mapping is crucial for developing smarter, highly targeted cancer treatments in the future.
However, this cutting-edge technology comes with a steep price tag. The Atera instrument costs $495,000, creating a significant financial hurdle for laboratories, particularly those that recently invested in the older Xenium system. Beyond the initial purchase, running these comprehensive genetic tests requires specialized chemical probes, meaning the ongoing costs to operate the machine will remain high.
Interested in Genomics?
Newsletter
Never miss a breakthrough.
Join 10,000+ curious minds getting biotech stories distilled into plain language. Free, three times a week.